An Open-Label Pilot Study to Assess the Safety of Oral Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy.

Trial Profile

An Open-Label Pilot Study to Assess the Safety of Oral Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2015

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Generalised epilepsy
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 04 Dec 2012 Results were presented at the 66th Annual Meeting of the American Epilepsy Society (AES) in December 2012
    • 23 Nov 2010 Planned End Date changed from Mar 2011 to Sep 2011 as reported by ClinicalTrials.gov.
    • 19 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top